Cesare Orlandi
2018
In 2018, Cesare Orlandi earned a total compensation of $1.1M as Chief Medical Officer at Lantheus Holdings, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,593 |
|---|---|
| Salary | $414,484 |
| Stock Awards | $494,131 |
| Other | $12,375 |
| Total | $1,133,583 |
Orlandi received $494.1K in stock awards, accounting for 44% of the total pay in 2018.
Orlandi also received $212.6K in non-equity incentive plan, $414.5K in salary and $12.4K in other compensation.
Rankings
In 2018, Cesare Orlandi's compensation ranked 8,571st out of 14,244 executives tracked by ExecPay. In other words, Orlandi earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,571 out of 14,244 | 40th |
Division Manufacturing | 3,412 out of 5,759 | 41st |
Major group Chemicals And Allied Products | 1,285 out of 2,122 | 39th |
Industry group Drugs | 1,073 out of 1,811 | 41st |
Industry In Vitro and In Vivo Diagnostic Substances | 32 out of 72 | 56th |
Source: SEC filing on March 15, 2019.
Orlandi's colleagues
We found four more compensation records of executives who worked with Cesare Orlandi at Lantheus Holdings in 2018.